PRO ONCO DUCTS

Infliximab

Infliximab

Infliximab is a tumour necrosis factor alpha (TNFα) inhibitor, the first-line biologic therapy in patients with a number of immune-mediated inflammatory diseases: rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease and ulcerative colitis, psoriasis and psoriatic arthritis.
Interferon beta-1b

Interferon beta-1b

the first Russian human recombinant interferon beta-1b used in the treatment of multiple sclerosis. Launched in 2009.

adalimumab

anti IL-17 mAb

Tenexia® (pegylated interferon beta-1a)

anti IL-6R mAb

anti CD20 mAb

anti IL-5R mAb